SIRIS-Lab/unlabelled-sti-corpus huggingface dataset:
Using Genetic Programming to Find Technical Trading Rules for SSE 50 Index

To avoid data snooping bias induced by the common approach of testing market efficiency through popular technical trading rules,genetic programming is proposed to find optimal technical trading rules.The first generation of technical trading rules is randomly generated tree structures of basic functions,optimized by genetic programming.Data are divided into training period and testing period using moving windows.The technical trading rules get optimized generation by generation using the training data,while the subsequent testing data are used to test the optimization result′s out-of-sample performance.Using daily price and volume data for the SSE 50 index from January 2,2004 to March 12,2010,we find out that genetic programming generated best technical trading rules have statistically significant out-of-sample excess return compared with buy-and-hold considering realistic transaction cost.Therefore,we conclude that Chinese stock market has not achieved weak-form efficiency.
WOMEN IN NET 8

WINNET 8 involves regions in 8 member states i.e Bulgaria, Finland, Greece, Italy, Poland, Portugal, Sweden and UK engaged in policy development to address the problems with low employment rates among women in combination with  horizontally segregated labour markets and the lack of women in entrepreneurship, innovation and technology, Problems constituting obstacles for regional competitiveness. The participating regions from the Nordic countries has among the most horizontally segregated labour markets in EU-27, whilst the regions involved from South and East Europe is less segregated. On the other hand the employment rates among women is lower. The consortium builds on a successful practices from the III C project W.IN.NET- mentioned in the Operational Program for IV C - and the III B Baltic Sea project FEM were several of the partners has been involved.
The partner regions involved in these Interreg projects have since 2006 discussed how to capitalize the successful results from cooperation initiatives between Women Resource Centers and regional actors. The Nordic Conference 19 October 2007 in Stockholm, was one event for this dialogue 
WINNET 8 involves local and regional authorities, Managing Authorities, research institutes and NGOs. The overall objective is to contribute to regional growth by enhancing the labour market participation among women and especially promotes women in entrepreneurship, innovation and technology. WINNET8 will reinforce the Roadmap for Equality between Women and Men and the gender dimension in the Lisbon Agenda. The project will build capacity for implementation of policies, practices and Women Resource Centres (WRC)
Regional action planning will be at the core of the project supported by a number of interregional exchanges such as a Launching Conference during the Swedish EU Presidency, a training for process coaches in order to facilitate both drawing up of action plans and implementation after the project period. Regional action plans taken as a point of departure validated practices and state of the art research, mobilize actors, each Regional Multi-Actor Group established will also be engage in a an advanced bench learning and study visit program capitalizing on successful results of similar actions in Interreg III C. Expected results are besides the actions plans are reformed and improved policies for local and regional development, increased knowledge in the regions how to design policies and practices promoting women in entrepreneurship, innovation and technology and counteracting horizontal gender segregation.
Analysis of acid rain's characteristics and variation tendency in longli experimental plot, guizhou.

From April 2007 to December 2008,the rainfalls had been collected and measured at Longli experimental plot in Guizhou Province.The acidity and chemical composition of rainwater were analyzed with statistical methods to reveal the characteristics and seasonal tendency of local acid rain.76.7% of the total capacity of rainwater were acidic with an average pH value of 4.70 and the frequency of acid rain accounted for 70.1% during the study period.Meanwhile,the concentrations of SO42-,NO3-,NH4+,Ca2+ of rainwater were higher in spring with much more occurrences of acid rain.As a conclusion,the wet depositions of sulfur and nitrogen did not exceed the critical loads estimated by the other studies.
Screening for liver fibrosis - population-based study across european countries

Liver cirrhosis is a very common and severe chronic disease, responsible for high morbidity, impaired quality of life, major healthcare costs, and poor survival, causing an estimated 170,000 deaths per year in Europe. Liver cirrhosis is preceded by a long period of slowly developing, asymptomatic, liver fibrosis; most commonly caused by non-alcoholic fatty liver disease (NAFLD, related to obesity and type 2 diabetes), alcohol, and hepatitis B or C virus infection. There is no treatment available to reverse advanced liver cirrhosis.  However, if fibrosis could be detected early, all of the major causes are still amenable to prevention and treatment. Early diagnosis of liver fibrosis in the general population is therefore crucial for the estimated 10 million Europeans with undetected liver fibrosis.

The LiverScreen project aims to develop a targeted screening methodology to identify persons with asymptomatic liver fibrosis and cirrhosis among the general population. This methodology involves: 1) identification of groups from the general population at high risk of having chronic liver disease, 2) screening their liver stiffness with the innovative transient elastography (TE) technology (until now only validated in patients with known liver disease) for diagnosis, and 3) determining the right follow-up screening regime. Within the LiverScreen project 8 European countries will collaborate and perform research in over 34,000 subjects to develop the screening methodology and demonstrate its accuracy, clinical value, cost-effectiveness, acceptability, and potential to be implemented by healthcare systems throughout Europe.

Using the LiverScreen program, diagnosis at an early stage can stop liver disease progression and have a subsequent long-term impact on liver disease morbidity and mortality and the associated societal burdens in terms of economic costs and health inequity. The estimated cost reduction ranges from €850 to €4,000 per quality-adjusted life-year gained.
Analysis of monthly cloud climatology of the Indian subcontinent as observed by TRMM precipitation radar

Tropical Rainfall Measuring Mission Precipitation Radar data (2A23 V7), for a period of 9 years (2002–2010), is used to analyse the evolution of the monthly cloud climatology over the Indian subcontinent (lat. 6.5°–38.5°N, long. 66.5°–100.5°E). The analysis of the cloud data suggests that over most regions and seasons, the stratiform cloud fraction is associated with outflows from and remnants of convective cells. However, the stratiform cloud cover over the North Indian subcontinent during winter season is not accompanied by any convective cloud maximum zone, indicating minimal role of ground processes in the growth of cloud cover over the region during this season. Mesoscale factors and land surface processes play a major role in the development of cloud maxima during March to May over the Indian subcontinent, over the eastern Himalayas and adjoining plains, as well as southwest peninsular India. As the summer monsoon season approaches, the spatial spread and growth of both cloud fractions gradually increase (stratiform fraction of cloud cover increases rapidly, while the convective fraction rises gradually) over east India, Bay of Bengal and over south Arabian Sea, indicating increased organization of the cloud systems with longer lasting stratiform outflows with the advancement of the season. The largest cloud maxima during the monsoon season are observed at the windward side of hills along the west coast of peninsular India and the west coast of Myanmar. The respective values of convective and stratiform cloud fractions indicate that the cloud cover over Myanmar is associated with more organized cloud systems with larger stratiform outflows, as compared with clouds along the west coast of peninsular India. Similarly, during October to December, the increasing stratiform cloud fractions over southeast peninsular India indicate increasing organization of clouds, compared with values during the monsoon season over this region.
Automotive derivative energy system

The overall aim is to create the foundations for commercializing an automotive derivative fuel cell system in the 50 to 100 kW range, for combined heat and power (CHP) applications  in commercial and industrial buildings.  More specifically, the project has the following objectives:
• develop system components allowing reduced costs, increased durability and efficiency 
• build and validate a first 50 kW PEM prototype CHP system 
• create the required value chain from automotive manufacturers to stationary energy end-users
Mass-market production of fuel cells will be a strong factor in reducing first costs. In this respect, joining the forces of two non-competing sectors (automotive and stationary) will bring benefits to both, to increase production volume and ultimately reduce costs to make fuel cells competitive. As a consequence, the project partners have identified a PEM fuel cell based CHP concept to address the stationary power market, primarily for commercial and industrial buildings requiring an installed capacity from about 50 kWe to some hundreds of kWe. The main components of the system have been validated to at least laboratory scale (TRL>4).   As a part of the present AutoRE proposal, the overall system will be demonstrated and further validated to increase the technology readiness level to TRL5. In addition, innovative solutions will be demonstrated to continuously improve performance and reduce costs and complexity. The project consortium reflects the full value chain of the fuel cell CHP system which will enhance significantly the route to market for the system/technology.  

The proposal relates to FCH-02.5-2014: Innovative fuel cell systems at intermediate power range for distributed combined heat and power generation, and it addresses the main specific challenges and scope laid down in the FCH JU AWP2014 to “develop, manufacturing and validation of a new generation of fuel cell systems with properties that significantly improve competitiveness"".
Modular element for external and internal architecture and external or internal architectural assembly made by assembling these elements

External or internal architectural assembly according to Claim 4 of the main patent comprising a sequence of modular elements, each consisting of a profile section having a cross section in the general form of a U whose dimensions are a multiple of those of one basic modular element, and in which perforations are arranged according to a repetitive and identical sequence. This assembly moreover comprises modular elements of like design comprising, at an intermediate point of their length, one or more openings 2 assuming one or more of the branches or wings of these elements. These elements may be used for making internal or external architectural parts. <IMAGE>
Drying device

A drying device A1 is provided with: a housing 10 having air intake openings 14, 15 and a discharge opening 11; a blower means 2 contained in the housing 10; a heating means 3 provided between the blower means 2 and the discharge opening 11 and heating air to be delivered by the blower means 2; and an extendible-contractible discharge section 5 provided at the discharge opening 11. The discharge section 5 extends in the direction of air delivery by the blower means 2 while being held on the discharge opening 11 side. As a result of this configuration, the discharge section 5 is unlikely to impair the appearance.
Innovations to accelerate vaccine development and manufacture

Inno4Vac proposes an ambitious programme that will harness the latest advances in immunology, disease modelling, and modelling for tackling persistent scientific bottlenecks in vaccine development and for de-risking and accelerating this process. To reach this aim the project is divided into  four interlinked subtopics. In Subtopic 1, artificial intelligence in combination with big data analysis and computational modelling will be used to build an open-access and cloud-based platform for in silico vaccine efficacy assessment and development. Subtopic 2 will develop new and improved controlled human infection models (CHIM) against influenza, RSV and C. difficile that will enable early vaccine efficacy evaluation. Subtopic 3 will contribute to the development of cell-based human in vitro 3D models that resemble the in vivo situation of an infection at the mucosa and more reliably predict immune protection. These models will be combined with the development of related functional immune assays for clinically relevant (surrogate) endpoints. Finally, Subtopic 4 will develop a modular one-stop computational platform for in silico modelling of vaccine bio-manufacturing and stability testing. 
In parallel to the scientific-technical work, the partners will develop strategies and roadmaps for positioning the newly developed models in the regulatory framework and integrating them into pharmaceutical vaccine development. The overall workplan is underpinned by horizontal activities on coordination/management and dissemination/communication, including data management and future sustainability.
To achieve these ambitious objectives, Inno4Vacc has assembled a multidisciplinary consortium from academic and research institutions, industries, regulatory bodies, and vaccine R&D alliances. This unique partnership brings together clinical, immunological, microbiological, systems biology, mathematical models, and regulatory expertise and includes world-leaders in each respective field.
PROCESS AND APPARATUS FOR PRODUCING A FEED STREAM FOR A STEAM REFORMING PLANT

The invention relates to a process and an apparatus for producing an olefin-containing feed stream for a steam reforming plant. According to the invention, the olefin-containing hydrocarbon starting material is for this purpose vaporized and catalytically hydrogenated. The hydrogenation product stream obtained is separated into a gaseous reforming feed stream, which is fed to a steam reforming plant, and a gaseous recycle stream. As a result of the cooling according to the invention of the gaseous recycle stream down to at least partial condensation thereof and the separate recirculation of the gaseous partial recycle stream and of the liquid partial recycle stream, the procurement of a large and complicated circulation compressor is avoided and electric energy for operating this compressor is saved.
Empowering rare disease patients: integrated personalized cloud patient monitoring platform

We own and run a cloud patient monitoring platform that consists of one part for healthcare professionals: uClinics and another one for patients: uPatient. uClinics allows doctors to prescribe and assess the patient and uPatient empowers patients to understand their health treatment. We want to adapt the design of these two applications through Phase I and II funding to rare diseases and call the project uMonitorRare. uClinics and uPatient are fully functional and being used by our three largest customers in over 70 countries and 5 continents.

For Phase II, the overall objective is the technical re-design and upgrade of our uClinics and uPatient suites for rare disease patients (integration of new monitoring protocols for rare diseases, integration of new devices adapted to new diseases, integration of the Platform to Health Information Systems, multi-source data aggregation, benchmarking technology). In Phase I, we need to conduct a Technical Feasibility Study and complete a Business Plan.
The uMonitorRare breakthrough ICT product will create a new market by offering an integrated rare diseases monitoring and management tool for rare disease patients. This is going to have a transformatory impact on rare disease patients who will become the universal patient at the center of attention.

According to the World Health Organization (WHO), there are nearly 7,000 rare diseases affecting 7% of world population. This means that 3 million people are affected by rare diseases throughout Spain and 30 million people are affected by rare diseases throughout Europe. Not only does this represent a major market potential, but also can it have a major impact on the way patients are treated.
Développer et mettre en œuvre une forme moderne de médicament avec une application facile, inhibant l’alopécie androgène et stimulant la repousse des cheveux chez les femmes et les hommes.

L’objectif de ce projet est de développer et de mettre en œuvre sur le marché polonais et sur certains marchés européens (France, Grèce, Italie et Allemagne), un médicament au minoxidil, sous forme de mousse de cuir chevelu qui n’est pas disponible pour les patients polonais. Ce produit sera dédié aux personnes souffrant d’alopécie androgène. Ce type de condition est la cause la plus fréquente de perte de cheveux chez les deux sexes, dont la fréquence et la gravité augmentent avec l’âge. Selon les derniers résultats, l’alopécie androgène affecte près de 3 femmes caucasiennes sur 10 de plus de 30 ans pour presque doubler la prévalence dans la population des femmes âgées de 80 ans et plus (57 % d’entre elles). Chez les hommes, cette maladie se produit généralement dans la troisième et quatrième décennie de vie et affecte entre 30 % et 50 % des hommes âgés de 50 ans et environ 80 % des hommes blancs de plus de 70 ans. [1] Il n’y a pas de produits sous forme de mousse sur le cuir chevelu sur le marché polonais du minoxidil. Presque toutes les préparations contenant du minoxidil sont vendues sous forme de liquides sur la peau, et seul l’alocutan est disponible en spray. De plus, il n’y a pas de produit sur le marché contenant du minoxidil à une concentration de 5 % qui pourrait être utilisé simultanément par les hommes et les femmes. Les produits pharmaceutiques disponibles avec cette dose sont pour les hommes seulement. L’objectif sera atteint grâce à la mise en œuvre de quatre étapes de R & D. À l’étape 1, la formulation et l’essai de pénétration dans la peau humaine (ex-vivo) seront effectués. Au cours de l’étape suivante, au moins une formulation sélectionnée effectuera des tests d’irritation cutanée in vitro et un test de potentiel de sensibilisation in vivo. L’étape 3 prévoit le transfert de technologie et de méthodes d’analyse à l’installation de l’OCM (OCM). Organisation de fabrication sous contrat) avec une mise à l’échelle simultanée jusqu’à l’échelle cible et la fabrication de séries d’enregistrement dans des conditions de BPF. Dans la dernière étape, la stabilité du produit fini sera testée
Beyond the mouse: Understanding user gestures for manipulating 3D objects from touchscreen inputs

Multi-touch interfaces have emerged with the widespread use of smartphones. Although a lot of people interact with 2D applications through touchscreens, interaction with 3D applications remains little explored. Most 3D object manipulation techniques have been created by designers who have generally put users aside from the design creation process. We conducted a user study to better understand how non-technical users tend to interact with a 3D object from touchscreen inputs. The experiment consists of 3D cube manipulations along three viewpoints for rotations, scaling and translations (RST). Sixteen users participated and 432 gestures were analyzed. To classify data, we introduce a taxonomy for 3D manipulation gestures with touchscreens. Then, we identify a set of strategies employed by users to perform the proposed cube transformations. Our findings suggest that each participant uses several strategies with a predominant one. Furthermore, we conducted a study to compare touchscreen and mouse interaction for 3D object manipulations. The results suggest that gestures are different according to the device, and touchscreens are preferred for the proposed tasks. Finally, we propose some guidelines to help designers in the creation of more user friendly tools.
Lean manufacturing as a high-performance work system: the case of Cochlear

This paper addresses the Special Issue call for Australian examples of innovative management systems that enable the production of successful products by drawing on a single case study: medical device manufacturer Cochlear. Through qualitative case study methodology, we examine the human resource management practices that complemented the implementation of lean manufacturing principles. We argue that in their implementation, Cochlear’s management team enriched the traditional understanding of lean and its focus on waste reduction, low cost and quality assurance by adopting people management practices as an integrated component of the overall management capability which allowed their people to grow and develop. The combination of lean and HR practices transformed Cochlear to a high-performance work system and positively impacted production processes and output. By examining a medical device manufacturer, an under-researched sector, our paper expands existing literature on lean manufacturing and provides im...
Research And Development – Investing On SMEs

For each country involved, the project RADIO SMEs, will support regional territories and local SMEs in defining and implementing research and innovation policies, whose final aim is the growth of SME competitiveness in terms of process innovation, development and adjustment of technologies, product innovation and in terms of human resource capacity improvement. The areas involved, in danger of economic marginalisation have common characteristics: the competitive gap can be found in the sectors that concern company productivity, corporate governance, and research expenditure. In particular Italy invests half of the EU-15 average in R&D, while the countries that are part of the EU-25 (amongst which Greece, Cyprus and Malta) add no more than 1.65% of the entire expenditure assumed by the Enlarged Union. The design logic is therefore based on the capacity to give support to regional territories in the definition and implementation of the R&D policies, through actions aimed at favouring the growth and quality of human resources, boost scientific and technological contents of the production, strengthen the local competence networks and the connections with the entrepreneurial system. The main objective of the project is to promote potential competitiveness by using of methodologies that are diversified according to the various bodies involved: SMEs, Continuing Education Organizations that apply new technologies, Universities, and sector Networks and Consortia. The activity will concern Italy in the provinces of Caserta (Campania), Matera and Potenza (Basilicata), Foggia (Puglia), Crotone and Catanzaro (Calabria), Siracusa (Sicily), while in Greece it will concern the area of Central Greece and the Evia Region. All actions and activities that will be developed can be to a large extent attributed to two macro objectives that make up its logical structure: 1) Innovation support through: • The mapping of the main public and private research centres and of the SME consultancy needs about Research and Development. • Collective and cooperative research (nationally and internationally) by specific sectors or by clusters and production chains, whose final aim is to increase the SME capacity to network; • Company Audits, whose aim is territorial development. 2) Development of an “Innovation Culture” through: • Dissemination and communication: seminars/workshops on technological innovation with leading companies; newsletter creation and diffusion; web site. • Actions that strengthen the competence system: benchmarking activities.